EGFR, a transmembrane glycoprotein, is significantly overexpressed in GBM, which helps to promote cell survival, proliferation, and chemoresistance by activating the ERK1/2 and PI3K/Akt/mTOR pathways [41,42]. The gene discussed is EGFR; the disease is glioblastoma.